Pharmaceutical manufacturers face increasing pressure to comply, standardise, and adapt; while navigating complex timelines, digital demands, and delivery expectations in a highly regulated environment:
Strict regulations, evolving GAMP standards, and precision demands
Manufacturers must standardise processes and documentation
Ensure both production and product quality at every stage - right from formulation to packaging
Meeting strict deadlines in fast-paced production eras
Adapting to peak demands with current resources is costly
Delivery delays hinder market entry, impacting competitiveness
PLC, SCADA/HMI, Batch Control, MES Integration
Data Integrity, 21 CFR Part 11, GAMP 5 Validation
Track & Trace, Vision Inspection, Labeling Solutions
BMS, HVAC, Particle Monitoring
System Architecture, Mechanical, and Electrical Design
Compliance through IQ, PQ, OQ, DQ and Validation Protocols
Support Project Lifecycle and Regulatory Submissions
MES for Real-Time Production Tracking and Optimisation
Greenfield and Brownfield Project Execution
At Sarla Technologies, we understand the complexities of pharmaceutical manufacturing. We specialise in offering profound insights into both primary Active Pharmaceutical Ingredient (API) production, secondary processing and managing sterilisation processes.
This stage involves the synthesis, purification, and characterisation of the API, the compound responsible for the therapeutic effect of the drug
These are the individual steps involved in transforming the API into a final dosage form:
Sarla Technologies is revolutionising pharmaceutical manufacturing worldwide. Our projects range from comprehensive automation engineering for sterile liquid processing, intraocular lens packaging lines, and pharmaceutical batch production to complex system migrations.
